CDC Surveillance System: Age of Patients

Prevalence and Incidence

View Prevalence and Incidence Summary

Prevalence of CKD in the General Population

Prevalence of CKD in the Health Care System Population

Incidence of CKD in the Health Care System Population

Prevalence of CKD Towards Tracking Healthy People 2030 Goals

Awareness

View Awareness Summary

Person Awareness of CKD

Provider Awareness of CKD

CKD with ICD-9-CM Codes Among U.S. Veterans with CKD Stages 3-5

CKD Awareness Towards Tracking HP2020 Goals

Increase the Proportion of Adults with Chronic Kidney Disease Who Know They Have It

Burden of Risk Factors

View Burden of Risk Factors Summary

Diabetes in the General Population

Diabetes in the Health Care System Population

U.S. Adults with a Diagnosis of Diabetes

Hypertension in the General Population

Hypertension in the Health Care System Population

U.S. Adults with a Diagnosis of Hypertension

Obesity in the General Population

CVD in the General Population

Smoking in the General Population

Age in the Health Care System Population

Age of U.S. Adults

Race/Ethnicity in the Health Care System Population

U.S. Adults by Race/Ethnicity

Food Insecurity in CKD

Health Consequences

View Health Consequences Summary

Mortality in CKD in the Health Care System Population

Mortality Rates by eGFR Category/stage

Physical and Mental Functioning in CKD

Risk Factors for Progression of CKD

Progression

One-year Progression of CKD in U.S. Veterans

Risk Factors for CKD Complications Towards Tracking HP2020 Goals

Quality of Care

View Quality of Care Summary

Laboratory Testing for CKD in the Health Care System

Nephrology Care Prior to ESRD

Use of Medications in CKD

Blood Pressure Treatment and Control in CKD

Trends in Hypertension Diagnosis, Treatment, and Control Among Us Veterans

Health Care System Capacity

View Health Care System Capacity Summary

Skip directly to View Data

Indicator Details: Age of Patients

Data Sources

Stratification and Year Choices:

Source

CMS-Medicare
NATIONAL VA
Clinformatics Commercial
Clinformatics Medicare Advantage
CMS-Medicaid

View Data By:

Year, Age
Gender, Year, Age
Age, Race/Ethnicity

Chart Format

Bar
Line
Stacked Bar Confidence Intervals

Chart Colors

Contrast
Gradient

Select a state from the dropdown below

Filter By:

Sort By:

+ View Data Table

Download Table

Age of Patients by Gender and Year and Age Clinformatics Medicare Advantage
Year	Age	Male	Female
2006	65–69 years	40.7% (CI 40.5-40.9)	37.1% (CI 36.9-37.2)
2006	70–79 years	55.7% (CI 55.4-55.9)	57.7% (CI 57.5-57.9)
2006	80–89 years	3.6% (CI 3.5-3.7)	5.1% (CI 5.0-5.2)
2006	90+ years	.0% (CI .0-.0)	.1% (CI .1-.1)
2007	65–69 years	41.4% (CI 41.2-41.6)	37.7% (CI 37.5-37.8)
2007	70–79 years	54.7% (CI 54.5-54.9)	56.8% (CI 56.6-57.0)
2007	80–89 years	3.9% (CI 3.8-3.9)	5.4% (CI 5.4-5.5)
2007	90+ years	.0% (CI .0-.0)	.1% (CI .1-.1)
2008	65–69 years	41.9% (CI 41.7-42.1)	38.1% (CI 38.0-38.3)
2008	70–79 years	54.0% (CI 53.8-54.2)	56.1% (CI 55.9-56.2)
2008	80–89 years	4.1% (CI 4.0-4.1)	5.7% (CI 5.6-5.7)
2008	90+ years	.0% (CI .0-.1)	.1% (CI .1-.1)
2009	65–69 years	42.5% (CI 42.3-42.7)	39.1% (CI 39.0-39.3)
2009	70–79 years	53.5% (CI 53.4-53.7)	55.3% (CI 55.2-55.5)
2009	80–89 years	3.9% (CI 3.9-4.0)	5.5% (CI 5.4-5.5)
2009	90+ years	.0% (CI .0-.0)	.1% (CI .1-.1)
2010	65–69 years	42.6% (CI 42.5-42.8)	39.7% (CI 39.6-39.8)
2010	70–79 years	53.4% (CI 53.2-53.5)	54.8% (CI 54.7-54.9)
2010	80–89 years	4.0% (CI 3.9-4.0)	5.4% (CI 5.3-5.4)
2010	90+ years	.0% (CI .0-.0)	.1% (CI .1-.1)
2011	65–69 years	41.0% (CI 40.9-41.2)	38.8% (CI 38.7-38.9)
2011	70–79 years	47.8% (CI 47.7-48.0)	46.1% (CI 46.0-46.2)
2011	80–89 years	11.1% (CI 11.0-11.2)	15.0% (CI 14.9-15.1)
2011	90+ years	.0% (CI .0-.0)	.1% (CI .1-.1)
2012	65–69 years	39.0% (CI 38.9-39.1)	37.4% (CI 37.3-37.5)
2012	70–79 years	48.6% (CI 48.5-48.7)	46.4% (CI 46.3-46.5)
2012	80–89 years	12.4% (CI 12.3-12.4)	16.1% (CI 16.1-16.2)
2012	90+ years	.0% (CI .0-.0)	.1% (CI .1-.1)
2013	65–69 years	37.4% (CI 37.3-37.6)	36.4% (CI 36.3-36.5)
2013	70–79 years	49.3% (CI 49.2-49.4)	46.7% (CI 46.6-46.8)
2013	80–89 years	13.2% (CI 13.1-13.2)	16.8% (CI 16.7-16.9)
2013	90+ years	.1% (CI .1-.1)	.1% (CI .1-.1)
2014	65–69 years	34.1% (CI 34.0-34.2)	33.3% (CI 33.2-33.4)
2014	70–79 years	50.7% (CI 50.6-50.8)	47.9% (CI 47.8-47.9)
2014	80–89 years	15.1% (CI 15.0-15.2)	18.7% (CI 18.7-18.8)
2014	90+ years	.1% (CI .1-.1)	.1% (CI .1-.1)
2015	65–69 years	32.6% (CI 32.5-32.7)	32.0% (CI 31.9-32.1)
2015	70–79 years	50.8% (CI 50.7-50.9)	47.7% (CI 47.6-47.8)
2015	80–89 years	16.6% (CI 16.5-16.7)	20.2% (CI 20.1-20.3)
2015	90+ years	.1% (CI .1-.1)	.1% (CI .1-.1)
2016	65–69 years	32.0% (CI 32.0-32.1)	31.4% (CI 31.3-31.5)
2016	70–79 years	50.7% (CI 50.6-50.8)	47.9% (CI 47.8-48.0)
2016	80–89 years	17.2% (CI 17.1-17.3)	20.6% (CI 20.5-20.7)
2016	90+ years	.1% (CI .1-.1)	.1% (CI .1-.1)
2017	65–69 years	31.1% (CI 31.0-31.2)	30.3% (CI 30.2-30.3)
2017	70–79 years	50.3% (CI 50.2-50.3)	47.6% (CI 47.5-47.6)
2017	80–89 years	18.5% (CI 18.5-18.6)	22.0% (CI 21.9-22.0)
2017	90+ years	.1% (CI .1-.1)	.2% (CI .2-.2)
2018	65–69 years	30.0% (CI 29.9-30.1)	28.9% (CI 28.9-29.0)
2018	70–79 years	50.0% (CI 50.0-50.1)	47.6% (CI 47.5-47.6)
2018	80–89 years	19.9% (CI 19.8-19.9)	23.3% (CI 23.3-23.4)
2018	90+ years	.1% (CI .1-.1)	.2% (CI .2-.2)
2019	65–69 years	29.1% (CI 29.0-29.1)	27.7% (CI 27.7-27.8)
2019	70–79 years	49.5% (CI 49.5-49.6)	47.4% (CI 47.3-47.4)
2019	80–89 years	21.2% (CI 21.1-21.2)	24.5% (CI 24.5-24.6)
2019	90+ years	.2% (CI .2-.2)	.4% (CI .3-.4)
2020	65–69 years	29.3% (CI 29.2-29.3)	27.6% (CI 27.6-27.7)
2020	70–79 years	48.6% (CI 48.5-48.6)	46.8% (CI 46.7-46.8)
2020	80–89 years	22.0% (CI 21.9-22.0)	25.2% (CI 25.2-25.3)
2020	90+ years	.2% (CI .2-.2)	.3% (CI .3-.3)

Notes:

* Indicates that the result for this cell was suppressed because of imprecision due to a sample size that was too small or the standard error of the result being too large (>30% of the estimate).
95% confidence intervals, when available, are shown in parentheses.

The population aged 65 years or older enrolled in Clinformatics Medicare Advantage is primarily white for the years analyzed for patients enrolled in Clinformatics Medicare Advantage insurance.

Chart Explanation: The chart shows on the y-axis (vertical line) the percentage of patients, and the x-axis (horizontal line) shows the age groups by year, gender, and race.

The Clinformatics Medicare Advantage dataset provides paid medical and prescription claims and enrollment information for participants in Medicare Advantage plans of a large U.S. managed care health insurance company.

CKD is defined using ICD-9-CM or ICD-10-CM diagnosis codes, and ESRD is based on ICD diagnosis, CPT procedure, and DRG codes in the Clinformatics Medicare Advantage.

Field	Data
Description of Measure	Percentage of Medicare Advantage Clinformatics patients by age, race/ethnicity, gender, diabetes diagnosis and hypertension diagnosis
Data Source	Medicare Advantage Clinformatics from Optum Clinformatics data mart database (OptumInsight, Eden Prairie, MN)
Type of Data Source	Administrative
Data Set	Medicare Advantage Clinformatics enrollees aged 65 years or older
Health Care System Data	Yes
Regional or National	Regional
Demographic Group	Patients aged 65 years or older enrolled in Medicare Advantage Clinformatics insurance
Numerator	Patients in denominator by age, race/ethnicity, sex/gender, diabetes status and hypertension status
Denominator	Patients aged 65 years or older with a full year of enrollment in a given calendar year
Primary Data Source Indicator	Diagnosis code from inpatient and outpatient files
Primary Indicator Method of Measurement	Medical claim
Secondary (1) Variable	Age in years at the end of the current calendar year
Secondary (2) Variable	Race/ethnicity
Secondary (3) Variable	Sex/gender
Secondary (4) Variable	Diabetes status determined by the presence of an ICD-9-CM or ICD-10-CM code for diabetes or diabetic complications, on at least one inpatient, outpatient, or medical services claim during a given calendar year
Secondary (5) Variable	Hypertension status determined by the presence of an ICD-9-CM or ICD-10-CM code for hypertension on at least one inpatient, outpatient or medical services claim during a given calendar year.
Period Currently Available	2016
Limitations of Indicator	The use of an ICD-9-CM or ICD-10-CM diagnosis code as a measure of prevalence, will underestimate the level of diabetes or hypertension in the general population
Analytical Considerations	In published literature, CKD is diagnosed by ICD-9-CM or ICD-10-CM codes in alternate ways (one outpatient, two or more outpatient or one inpatient claim). Care must be taken in comparisons.
ICD-9-CM Codes for CKD	016.0, 095.4, 189.0,189.9, 223.0, 236.91, 250.4, 271.4, 274.1, 283.11, 403, 404, 440.1, 442.1, 477.3, 572.4, 581-588, 591, 642.1, 646.2, 753.12-753.19, 753.2, 794.4
ICD-10-CM Codes for CKD	A18.11, A52.75, B52.0, C64.x, C68.9, D30.0x, D41.0x-D41.2x, D59.3, E08.2x, E09.2x, E10.2x, E10.65, E11.2x, E11.65, E13.2x, E74.8, I12.xx, I13.0, I13.1x, I13.2, K76.7, M10.3x, M32.14, M32.15, N01.x-N08.x, N13.1, N13.1x-N13.39, N14.x,N15.0, N15.8, N15.9, N16, N17.x, N18.1-N18.5, N18.8, N18.9, N19, N25.xx, N26.1, N26.9, O10.4xx, O12.xx, O26.83x, O90.89, Q61.02, Q61.1x-Q61.8, Q26.0-Q26.39, R94.4

Suggested Citation:

Centers for Disease Control and Prevention. Chronic Kidney Disease Surveillance System—United States.
website. http://www.cdc.gov/ckd